Genprex
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -4,461 | -3,505 | -3,343 | -4,673 |
EBIT | 12,451 | -4,674 | ||
Net Income | -4,461 | -3,790 | -3,799 | -4,674 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,138 | -4,098 | -3,187 | -3,864 |
Cash | 18,049 | 7,830 | 1,103 | 1,346 |
Basic Shares | 6,951 | 932 | 760 | 551 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -15 | -25 | |
EBITDA | -15,489 | -21,104 | -30,845 | -23,715 |
EBIT | -21,111 | -30,860 | -23,740 | |
Net Income | -16,228 | -21,111 | -30,860 | -23,740 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,311 | -17,149 | -24,809 | -17,778 |
Cash | 7,830 | 1,601 | 6,737 | 20,954 |
Basic Shares | 932 | 80 | 27 | 23 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.64 |
2025-12-31 | -$1.15 |
2025-09-30 | -$5 |
2025-06-30 | -$8.47 |